Brain GSH levels in patients with PD are decreased, and the dopamine D2 receptor (DRD2) in astrocytes can regulate the synthesis of GSH through pyruvate kinase isozyme type M2 (PKM2)-mediated transactivation of Nrf2. Here, DRD2 is linked to Parkinson disease.